K-numberK253595
Device nameEPIQ Series Diagnostic Ultrasound System, Affiniti Series Diagnostic Ultrasound System
ApplicantPhilips Ultrasound, LLC
Product codeIYN
Device classClass II
Decision dateMar 27, 2026
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The EPIQ Series and Affiniti Series Diagnostic Ultrasound Systems are diagnostic ultrasound imaging devices with a new Artificial Intelligence (AI) Auto Measure Abdomen software feature that provides semi-automated, editable measurements of abdominal organs such as kidney and spleen to improve workflow efficiency. The systems are used for diagnostic ultrasound imaging and fluid flow analysis across multiple clinical indications including abdominal, cardiac, obstetric, gynecological, and peripheral vascular applications in clinics, hospitals, and point-of-care settings.

Technological characteristics

The proposed device adds the Auto Measure Abdomen AI software feature to existing EPIQ and Affiniti systems, enabling semi-automated measurement of kidney sagittal length, kidney transverse width, kidney transverse height, and spleen length. The feature is available only on C5-1 and C9-2 transducers and requires software version 14.0 or higher. All other hardware, imaging modes, software architecture, and device classification remain identical to the predicate.

Test standards cited

IEC 62304 (Medical device software – Software life cycle processes, 2006 + A 2015), ISO 14971 (Medical devices – Application of risk management to medical devices, 2019), and the FDA Guidance for Industry and FDA Staff – Marketing Clearance of Diagnostic Ultrasound Systems and Transducers (February 2023).

Substantial equivalence argument

The proposed device is substantially equivalent to predicate K243794 because both are indicated for diagnostic ultrasonic imaging and fluid flow analysis with identical intended users, use environments, device classification, product codes, software architecture, and hardware/imaging modes. The key difference—that Auto Measure in the predicate is for cardiac indication while the proposed Auto Measure Abdomen is for abdominal indication—does not raise new safety or effectiveness questions, as both are software-only changes to previously cleared systems. Performance validation showed the AI algorithm measurements have strong concordance with expert manual measurements across a diverse population.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →